Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
Luigi Gennari, Daniela Merlotti, Ranuccio NutiDepartment of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, University of Siena, Siena, ItalyAbstract: Selective estrogen receptor modulators (SERMs) represent a class with a growing number of compounds that act as either estrogen rec...
Saved in:
| Main Authors: | Luigi Gennari, Daniela Merlotti, Ranuccio Nuti |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2010
|
| Subjects: | |
| Online Access: | https://doaj.org/article/710260fdbd414cfe956d013b4a9c7646 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
by: Kawate H, et al.
Published: (2011) -
Alta prevalencia de osteoporosis en mujeres mapuches postmenopáusicas asintomáticas
by: Ponce L,Lucía, et al.
Published: (2002) -
Muscular strength measurements indicate bone mineral density loss in postmenopausal women
by: Zhou Z, et al.
Published: (2013) -
Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty
by: Tao Y, et al.
Published: (2021) -
Association between Bone Mineral Density and Metabolic Syndrome among Reproductive, Menopausal Transition, and Postmenopausal Women
by: Rogelio Salas, et al.
Published: (2021)